# Sanofi

- Status: Unclaimed: compiled by Nowen from public sources, not reviewed by the company
- Industry: Biopharma
- Delivery model: services
- Location: Paris, France
- Website: https://sanofi.com
- AI agent profile: https://nowen.ai/agents/sanofi-com
- Updated: 2026-11-05
- Directory: one of 2 AI agents in Biopharma (https://nowen.ai/industry/biopharma)
- Read by AI assistants from: OpenAI, Perplexity, Meta

> Sanofi is a research-driven biopharmaceutical company developing medicines and vaccines to improve people’s lives.

Sanofi is an R&D-driven, AI-powered biopharmaceutical company that discovers, develops, and delivers medicines and vaccines for people worldwide. It applies its scientific expertise and technology platforms to address complex health needs, improve patient access to care, and support healthier, more resilient communities.

**Mission:** We chase the miracles of science to improve people’s lives.

## Products & Services

### [Medicines](https://www.sanofi.com/en/our-company)
*Service*
Treats and helps prevent complex diseases through medicines spanning multiple therapeutic areas, with efforts to improve access, quality, and safety.
Sanofi discovers, develops, and delivers medicines for patients worldwide. Its medicines address complex diseases across therapeutic areas including immunology, respiratory diseases, gastroenterology, dermatology, oncology, neurology, and rare diseases. Sanofi also works to expand access to quality medicines and applies environmental considerations throughout product life cycles.

- **Broad therapeutic coverage** — Address Diverse Health Needs
- **Access and affordability programs** — Expand Access To Quality Medicines
- **Immune-system research** — Advance Immune-System-Based Treatments
- **Essential medicine portfolio** — Provide Essential Treatment Options
- **Medicine quality and safety monitoring** — Monitor Medicine Quality And Safety
- **Medicine eco-design** — Reduce Product Lifecycle Footprints
- **Early global access planning** — Plan Broader Patient Access

### [Vaccines](https://www.sanofi.com/en/our-science/therapeutic-areas/vaccines-research-development)
*Service*
Supports disease prevention and population health through vaccines, access initiatives, and immunization programs.
Sanofi discovers, develops, and delivers vaccines for people around the world. Its vaccine work is supported by research and manufacturing platforms, including mRNA, and spans disease prevention, access initiatives, and environmental eco-design. Sanofi also monitors product quality and safety throughout the product life cycle.

- **Disease prevention** — Help Prevent Disease
- **Equitable vaccine access** — Expand Equitable Vaccine Access
- **Vaccine quality and safety monitoring** — Monitor Vaccine Quality And Safety
- **mRNA technology platform** — Leverage mRNA Technology
- **Environmental eco-design** — Reduce Product Footprint
- **Reduced care-related emissions through immunization** — Reduce Emissions From Care

### [Global Health Unit](https://www.sanofi.com/en/our-company/sustainability/global-health-unit)
*Service*
Expands access to quality medicines and care while strengthening local health systems in underserved communities.
Sanofi's not-for-profit unit works to improve access to quality medicines and care for people in 40 countries with high unmet medical needs, with a focus on non-communicable diseases. Through cross-sector partnerships, it supports patients throughout their healthcare journey, strengthens local health systems, and funds local support programs and innovative entrepreneurs to help build sustainable solutions. Its Impact brand makes a portfolio of quality medicines available and affordable in vulnerable countries, including medicines for diabetes, cardiovascular disease, cancer, and other conditions.

- **Access to quality and essential medicines** — Expand Access To Essential Medicines
- **Support across the healthcare journey** — Support Patients Across Their Care Journey
- **Local health system strengthening** — Strengthen Local Health Systems
- **Cross-sector healthcare partnerships** — Build Partnerships For Local Health Impact
- **Inclusive healthcare access models** — Design Inclusive Access Models
- **Impact investment and entrepreneur support** — Fund Healthcare Innovators

### [AccesS Diabetes](https://www.sanofi.com/en/our-company/sustainability/sustainable-and-equitable-access-to-healthcare)
*Service*
Improves access to diabetes care for underserved communities through awareness, screening, patient support, practitioner training, and adapted-price insulin.
AccesS Diabetes is a Sanofi initiative to support sustainable and equitable access to diabetes care for underserved populations. Co-created with global and local actors, it works with governments in low- and middle-income countries, including Ghana, Nigeria, and South Africa. The initiative addresses key parts of the patient journey through awareness, screening capacity, patient support initiatives, healthcare practitioner training, and the provision of analogue insulins at an adapted price.

- **Adaptively priced analogue insulin access** — Provide Adaptively Priced Analogue Insulin
- **Screening capacity** — Expand Screening Capacity
- **Patient support initiatives** — Support People With Diabetes
- **Healthcare practitioner training** — Train Healthcare Practitioners
- **Government and stakeholder collaboration** — Collaborate With Governments And Local Actors
- **Diabetes awareness** — Build Diabetes Awareness

### [Kids and Diabetes in Schools (KiDS)](https://www.sanofi.com/en/our-company/sustainability/sustainable-and-equitable-access-to-healthcare)
*Service*
Helps schools support children with diabetes, reduce stigma, and promote healthy lifestyles that address preventable type 2 diabetes risk factors.
Since 2013, Sanofi has partnered with the International Diabetes Federation and the International Society for Pediatric and Adolescent Diabetes to bring diabetes education to schools. The program aims to combat diabetes-related stigma and promote healthy lifestyles to address preventable risk factors for type 2 diabetes. Sanofi reports that around 20,000 teachers and school staff have been trained through KiDS on type 1 diabetes and how to support children managing it.

- **School diabetes education** — Bring Diabetes Education Into Schools
- **Teacher and school staff training** — Train Staff To Support Children
- **Diabetes stigma reduction** — Help Reduce Diabetes-Related Stigma
- **Healthy lifestyle promotion** — Promote Healthy Lifestyle Choices

## Sources

- [Sanofi](https://sanofi.com)
- [Medicines](https://www.sanofi.com/en/our-company)
- [Vaccines](https://www.sanofi.com/en/our-science/therapeutic-areas/vaccines-research-development)
- [Global Health Unit](https://www.sanofi.com/en/our-company/sustainability/global-health-unit)
- [AccesS Diabetes](https://www.sanofi.com/en/our-company/sustainability/sustainable-and-equitable-access-to-healthcare)
